HCMT
AMAG

Highland Capital Management (Texas)’s AMAG Pharmaceuticals AMAG Stock Holding History

Highland Capital Management (Texas)’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,200
Closed -$266K – 385
2018
Q1 		$266K Sell
13,200
-48,300
-79% -$817K 0.01% 298
2017
Q4 		$815K Hold
61,500
– – 0.04% 177
2017
Q3 		$1.14M Buy
+61,500
New +$1.15M 0.05% 183

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Highland Capital Management (Texas)'s AMAG Position: Q2 2018 in Review

Highland Capital Management (Texas) sold out of AMAG Pharmaceuticals (AMAG) in Q2 2018, closing a stake of 13,200 shares — an estimated $266K sold.

Highland Capital Management (Texas) first reported a position in AMAG in Q3 2017 and held it in 3 quarters. The position peaked at $1.14M in Q3 2017. 173 funds tracked by Wall St. Rank hold AMAG as of Q2 2018.

  • Highland Capital Management (Texas) reported no remaining AMAG Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 13,200 AMAG Pharmaceuticals shares in Q2 2018, an estimated $266K.
  • Highland Capital Management (Texas) first reported a position in AMAG Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Highland Capital Management (Texas)'s AMAG Pharmaceuticals position peaked at $1.14M in Q3 2017.
  • 173 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2018, filed 14 Aug 2018.